The 22nd International Congress on Luobing Theory convened in Shijiazhuang, Hebei on March 28 2026.
Academician Wu Yiling and his team unveiled a four‑volume Compendium of Luobing Theory covering theory, clinical applications, medicinals and health preservation.
Sub‑forums addressed cardiovascular, cerebrovascular, diabetes, respiratory, urological and cancer diseases, with an overseas forum planned for Singapore in autumn 2026.
The conference is categorized as an investor‑meet event and is expected to have neutral impact on markets.